~~<i id='52AF3A3D8E'><strike id='52AF3A3D8E'><tt id='52AF3A3D8E'><pre id='52AF3A3D8E'></pre></tt></strike></i>~~

00:00

00:00 00:00 LIVE

buffering

Replay

knowledge

author：Wikipedia 2025-09-30 00:48:28 - browse：618

The FDA building -- First Opinion coverage from STAT — Adobe

The Food and Drug Administration on Thursday approved the first medicine developed specifically to treat the serious liver disease known as MASH.

The pill, called Rezdiffra, is made by Madrigal Pharmaceuticals.

Metabolic dysfunction-associated steatohepatitis, or MASH, is often associated with obesity. The accumulation of fat in the liver causes inflammation, which leads to fibrosis, or liver scarring, and can progress in more advanced stages to cirrhosis, cancer, and the need for a liver transplant.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Malaria cases in Florida and Texas: Here’s what you need to know
Next article： How many hemophilia patients actually want gene therapy?

focus

knowledge

hotspot

focus

Wikipedia

entertainment

MarkWilson/NewsmakersWhentheWhiteHousereleasedPresidentBiden’s2025budgetrequeststhisweek,fundingforb

WSS

Case highlights the risks of experimental stem cell therapy

EPA limits use of carcinogenic gas for sterilizing medical devices

Second House panel advances two

Data integrity in scientific journals requires "effort" by publishers, institutions

Male and female sex labels in research insufficient, scientists say

Pushing for an NIH office for post

knowledge

knowledge

focus

The Supreme Court will review a ruling striking down a domestic violence federal gun ban

Boston's new lab space is opening empty

After affirmative action ruling, medical educators look to 'holistic review'

Boston's new lab space is opening empty

Drug repurposing or repositioning? The language matters

Readout Newsletter: Nvidia, Biogen, Ionis, AstraZeneca, ChatGPT

Psychedelics group wrestles with new pharma identity

Case highlights the risks of experimental stem cell therapy

Trump demands the U.S. pay no more for drugs than other countries … again

Amylyx ALS drug fails trial: Relyvrio patients react with fear, worry

knowledge

Venture capitalist Bob Kocher on the state of digital health

John Green on his newest strategy for fighting tuberculosis

Addiction experts warn against a second 'war on drugs'

Why scientists need input from humanists on sensitive research

Steward Health Care Massachusetts hospitals face fiscal disaster

Change Healthcare outage fallout shows need for new oversight

hotspot

focus

Wikipedia

entertainment